Immunotherapy of multiple sclerosis:: Where are we?: Where should we go?

被引：60
|
作者：
Martin, R
Stürzebecher, CS
McFarland, HF
机构：
[1] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA
[2] Schering AG, Clin Dev CNS, D-13342 Berlin, Germany
来源：
NATURE IMMUNOLOGY | 2001年 / 2卷 / 09期
关键词：
D O I：
10.1038/ni0901-785
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Differences in multiple sclerosis patient's disease and their responses to standard drugs indicate that today's therapies need to be more individualized. It is proposed that gene expression profiling in conjunction with magnetic resonance imaging be used to optimize future treatment approaches.
引用
收藏
页码：785 / 788
页数：4
相关论文
共 50 条
  • [31] Micronutrients in Maternal and Infant Health: Where We Are and Where We Should Go
    Yu, Yunxian
    NUTRIENTS, 2023, 15 (09)
  • [32] Dissemination research in cancer control: where are we and where should we go?
    Bowen, Deborah J.
    Sorensen, Glorian
    Weiner, Bryan J.
    Campbell, Marci
    Emmons, Karen
    Melvin, Cathy
    CANCER CAUSES & CONTROL, 2009, 20 (04) : 473 - 485
  • [33] The outcomes movement in orthopaedic surgery: Where we are and where we should go
    不详
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1999, 81A (05) : 732 - +
  • [34] CUREs in biochemistrywhere we are and where we should go
    Bell, Jessica K.
    Eckdahl, Todd T.
    Hecht, David A.
    Killion, Patrick J.
    Latzer, Joachim
    Mans, Tamara L.
    Provost, Joseph J.
    Rakus, John F.
    Siebrasse, Erica A.
    Bell, J. Ellis
    BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2017, 45 (01) : 7 - 12
  • [35] Smart energy: where do we stand and where should we go?
    Johann Kranz
    Lutz M. Kolbe
    Chulmo Koo
    Marie-Claude Boudreau
    Electronic Markets, 2015, 25 : 7 - 16
  • [36] Over-education and earnings: where are we, where should we go?
    Hartog, J
    ECONOMICS OF EDUCATION REVIEW, 2000, 19 (02) : 131 - 147
  • [37] The Elderly Patient and the ICU: Where Are We Going, Where Should We Go?
    Riou, Bruno
    Boddaert, Jacques
    CRITICAL CARE MEDICINE, 2016, 44 (01) : 231 - +
  • [38] Stress urinary incontinence: Where are we now, where should we go?
    DeLancey, JOL
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (02) : 311 - 319
  • [39] Pheochromocytoma - where are we? Where should we go? A medical and scientific odyssey
    Neumann, HPH
    Opocher, G
    Januszewicz, A
    Eng, C
    FAMILIAL CANCER, 2005, 4 (01) : 1 - 1
  • [40] Pheochromocytoma – where are we? Where should we go? A medical and scientific odysseyReview
    Hartmut P. H. Neumann
    Giuseppe Opocher
    Andrzej Januszewicz
    Charis Eng
    Familial Cancer, 2005, 4 : 1 - 1
12345